BooksTestimonialsInterviewsLibraryArticles 

Library

Library of Scientific Studies Funded and Published by others and Hepatitis C articles from other sources..

Hundreds of herbal remedies now outlawed across Europe

(NaturalNews) Live in Europe? Get your herbs while they last. New rules put forth by the European Union (EU) will ban the sale of certain herbal remedies that have been used for centuries.

Traditional herbs such a St. John's Wort or Echinacea must now meet strict licensing guidelines in order to be sold, while other lesser-known herbs that haven't been "traditionally" used in the last 30 years won't even make the cut to reach consumer shelves. Only those products that have been "assessed" by the Medicine and Healthcare products Regulatory Agency (MHRA) will be available for purchase. The real kicker? Even approved products will only be recommended for minor ailments such as the common cold, which means that product labeling may no longer be allowed to convey the potent health benefits of widely-used herbal remedies.

According the the EU, the laws were put in place to protect consumers from the "damaging" effects of traditional herbal remedies. The subtext of that statement, of course, is that herbal remedies can sometimes have dangerous interactions when taken with prescription drugs. Used alone, however, herbal supplements rarely pose a problem. With so many people taking prescription drugs, it's clear that the EU's move to ban herbal products is a monopolistic attack on the alternative health movement. While they can't admit the dangerous and deadly side effects of manufactured drugs, they can shift the blame to herbs.

Wobenzym Autoimmune, Toxic, Hepatitis B, Hepatitis C Studies

Hepatitis
Autoimmune Hepatitis, Toxic Hepatitis, Hepatitis B, Hepatitis C

Wobenzym in complex therapy of chronic liver diseases
Vasilenko A. M., Svec S. V. Wobenzym in complex therapy of chronic liver diseases. State Medical Academy in Dnepropetrovsk. II National Congress of Rheumatologists in the Ukraine, Kiev, 1997

Current complex therapy of chronic liver diseases focuses on elimination of basic pathogenetic syndroms of the disease. Glucocorticoids (GC) are the most effective in the treatment of chronic autoimmune hepatitis (CAH) and active liver cirrhosis (LC) with a significant autoimmune process. They appear to be effective regulators of immune reaction which suppress antibody production. One of the undesirable side-effects of GC is formation of circulating middle size immune complexes (CIC) which intensify cytolytic syndrom ( 1, 2, 4). One of the main characteristics of CIC - pathogenesity - is mainly determined by the size of complexes. Pathogenesity is caused, among others factors, also by a quantitative relation between antigen and antibody. During overproduction of antibodies against any antigen or in the case of equivalent relation when antigen is fully or partially bound, large CIC are formed. Mild excess of antigen over appropriate antibody (ratio 3:2) leads to a formation of middle sized immune complexes. Insufficient antibody production causes a formation of low molecular weight complexes. Literature data (l, 2, 4) show that cytolysis is higher when middle size CIC prevail. Optimal conditions for middle size CIC formation arise in 2nd - 3rd week of the treatment by big doses of GC. Wide use of GC is limited also by risk of possible side-effects: pathological changes in organs of digestive system and kidney, insufficient anti-inflammatory effect, impossible induction of remission of the disease. All above mentioned facts speak for a necessity to search for new methods to treat chronic liver diseases. Systemic enzyme therapy seems to be one of the prospective options.

Inflammation & Aging

Wobenzym is an enzyme preparation originally designed in Germany in the 1960s and is a natural anti-inflammatory with many additional health benefits.

Although its original use was primarily to treat osteoarthritis, studies have revealed that Wobenzym lowers C-reactive protein levels (a marker of chronic infection in the body) on average by 30%!

Study Finds that Natural Bioflavonoids Kill Hepatitis C Virus

Hepatitis C is an infectious disease of the liver that can cause miserable symptoms including fatigue, lack of appetite, abdominal pain, nausea and vomiting. Caused by a virus, hepatitis C affects about 200 million people worldwide. In the U.S. alone, one to two percent of the population is infected. Not only can this infectious disease cause scarring of the liver, cirrhosis, and eventually liver failure, but a significant number of people with hepatitis C also develop sometimes fatal liver disease or cancer.

Association of caffeine intake and histological features of chronic hepatitis C

Abstract

BACKGROUND & AIMS: The severity of chronic hepatitis C (CHC) is modulated by host and environmental factors. Several reports suggest that caffeine intake exerts hepatoprotective effects in patients with chronic liver disease. The aim of this study was to evaluate the impact of caffeine consumption on activity grade and fibrosis stage in patients with CHC.

NEW Studies Reveal Alarming Hidden Cause of Breast Cancer

By Russell L. Blaylock, MD, CCN

Vaccines Increase Cancer RiskBreast cancer is one of the leading causes of cancer death in women worldwide and breast cancer rates are increasing rapidly.

A compelling number of studies, though not all, have shown that free iron concentrations in breast tissue, especially the ductal tissue, is playing a major role in stimulating cancer development and eventual progression to aggressive, deadly cancers.1,2

Cancers are Very Dependent on Iron

Iron is needed for DNA replication in rapidly dividing cells.3

A recent report from the Department of Biomolecular Sciences in Urbino Italy, found that fluid taken from the nipple of cancer patients contained significantly higher levels of aluminum than did nipple fluid taken from women without breast cancer—approximately twice as much aluminum.4

A number of studies have found that extracting nipple fluid by a breast pump (in both premenopausal and postmenopausal women) is a simple way to study the microenvironment of the ductal tissue, the site of development of most breast cancers.5

Examining this ductal fluid is an excellent way to measure such things as iron levels, ferritin (an iron-binding protein), CRP (a measure of breast inflammation) and aluminum.

The researchers also found that women with breast cancer had much higher levels of ferritin, an iron transport protein, in their breast fluid, which was 5X higher in women with breast cancer.6

This observation has been confirmed in other studies.

In previous studies researchers found that one's intake of iron did not necessarily correlate with risk of breast cancer, but rather the release of iron from its protective proteins, such as ferritin and transferrin was critical.7

This distinction is very important and explains why some studies found no link between iron intake in the diet and breast cancer incidence.8

cannabis use on severity of hepatitis C disease (2008)

Abstract

BACKGROUND & AIMS: Complications of HCV infection are primarily related to the development of advanced fibrosis and whether cannabis use is a risk factor for more severe fibrosis is controversial.

METHODS: Baseline data from a prospective cohort study of 204 persons with chronic HCV infection were used for analysis. The outcome was fibrosis score on biopsy, and the primary predictor evaluated was daily cannabis use.

Syndicate content